Innovation1 Biotech Appoints Frederick E. Pierce, II to its Board of Directors
Retrieved on:
Thursday, September 15, 2022
Burn, Income, II, Glycogenesis, Inflammation, Senior advisor, Kidder, Peabody & Co., Hampshire College, Sale, Lehman Brothers, U.S. Securities and Exchange Commission, Schedule 1, Company, Fibromyalgia, OTCQB, Depression, Intellectual property, Private Securities Litigation Reform Act, Review, Climate Leadership Council, Hypertrophic scar, Cornea, Consulate, Epilepsy, Chronic fatigue syndrome, CEO, Genetics, List of life sciences, Acceleration, Investor relations, Solution, Cannabis, Board of directors, The Company, Merrill (company), Board, Security (finance), Post-traumatic stress disorder, SemBioSys Genetics, Fatigue, Marketing, GLOBE, Business development, Pharmaceutical industry, Management, Chemistry
Mr. Pierce is a serial biotech entrepreneur with more than 20 years of senior leadership and operating experience in building successful biotech companies.
Key Points:
- Mr. Pierce is a serial biotech entrepreneur with more than 20 years of senior leadership and operating experience in building successful biotech companies.
- He is the CEO and co-founder of Decoy Therapeutics, a pharmaceutical company that has created a rapid antivirals development platform.
- As a board member of the Canadian Entrepreneurs of New England, he serves as Chairman of the Life Sciences Leadership Council.
- Mr. Pierce brings a wealth of experience to our Board of Directors.